The Safety and Tolerability of Pirfenidone for BOS After HCT
NCT03315741
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Bronchiolitis Obliterans
Graft Vs Host Disease
Interventions
DRUG:
Pirfenidone 267 MG [Esbriet]
Sponsor
Stanford University
Collaborators
[object Object]